当前位置: X-MOL 学术Biomark. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells
Biomarker Research ( IF 9.5 ) Pub Date : 2020-11-10 , DOI: 10.1186/s40364-020-00240-1
Zhe Dai 1 , Xu-Yu Gu 1 , Shou-Yan Xiang 1 , Dan-Dan Gong 1 , Chang-Feng Man 1 , Yu Fan 1
Affiliation  

Malignant tumor is a largely harmful disease worldwide. The cure rate of malignant tumors increases with the continuous discovery of anti-tumor drugs and the optimisation of chemotherapy options. However, drug resistance of tumor cells remains a massive obstacle in the treatment of anti-tumor drugs. The heterogeneity of malignant tumors makes studying it further difficult for us. In recent years, using single-cell sequencing technology to study and analyse circulating tumor cells can avoid the interference of tumor heterogeneity and provide a new perspective for us to understand tumor drug resistance.

中文翻译:


单细胞测序在肿瘤异质性及循环肿瘤细胞耐药性中的研究及应用



恶性肿瘤是世界范围内危害极大的疾病。随着抗肿瘤药物的不断发现和化疗方案的优化,恶性肿瘤的治愈率不断提高。然而,肿瘤细胞的耐药性仍然是抗肿瘤药物治疗的巨大障碍。恶性肿瘤的异质性给我们进一步研究带来了困难。近年来,利用单细胞测序技术研究分析循环肿瘤细胞,可以避免肿瘤异质性的干扰,为我们了解肿瘤耐药性提供了新的视角。
更新日期:2020-11-12
down
wechat
bug